|Articles|August 1, 2017

Allergy and anaphylaxis emergency plan form

The American Academy of Pediatrics form for an allergy and anaphylaxis emergency plan.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

FDA news in pediatrics: August 2026

FDA news in pediatrics: August 2026

ByMorgan Ebert, Executive Editor

September 4th 2026

The unharmonious 2026 child and adolescent immunization schedule - addendum | Image Credit: © kamon_saejueng

The unharmonious 2026 child and adolescent immunization schedule - addendum

ByJoudeh B. Freij, MD, ScM,Bishara J. Freij, MD

September 4th 2026

The unharmonious 2026 child and adolescent immunization schedule | Image Credit: ©pingpao - stock.adobe.com.

The unharmonious 2026 child and adolescent immunization schedule

ByJoudeh B. Freij, MD, ScM,Bishara J. Freij, MD

September 4th 2026

What can pediatricians learn from food depictions in children's books?

ByCarol Duh-Leong, MD, MPP

September 4th 2026

FDA approves zilganersen (Zanvastro) as first treatment for Alexander disease

FDA approves zilganersen (Zanvastro) as first treatment for Alexander disease

ByMorgan Ebert, Executive Editor

September 3rd 2026

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

AAP expands RSV immunization recommendations for high-risk children

FDA approves zilganersen (Zanvastro) as first treatment for Alexander disease

Top 5 pediatric health headlines you missed in August 2026

HPV vaccination coverage stalls for fourth straight year as rural-urban gap persists, CDC finds

Evidence review supports respiratory virus immunizations for 2026-2027 season